FEATURES

Feature Articles

Targeting BRAF Mutation in Melanoma Treatment

Targeting BRAF Mutation in Melanoma Treatment

Advanced, metastatic melanoma is an aggressive disease with a poor prognosis; but therapies targeting gene mutations may offer hope to some patients.

Innovative Cancer Treatments Increase Patients' 'Financial Toxicity'

Innovative Cancer Treatments Increase Patients' 'Financial Toxicity'

Patients with cancer are living longer thanks to new cancer treatments; however, their financial well-being may suffer as a result.

The Search for Targeted Radiosensitizing Agents

The Search for Targeted Radiosensitizing Agents

Radiation therapy can cause morbidity in patients with cancer, so trials of radiosensitizing agents that can target tumors and save healthy tissue are in development.

Viewpoints

Increased Cancer Risk Found in 9/11 World Trade Center Rescue and Recovery Workers

Increased Cancer Risk Found in 9/11 World Trade Center Rescue and Recovery Workers

Within 7 years of the World Trade Center attacks, police, firefighters, and others who worked at Ground Zero faced a higher risk of cancer.

Endoscopic Ultrasound: An Innovative Way to Administer Chemotherapy

Endoscopic Ultrasound: An Innovative Way to Administer Chemotherapy

Although further safety data is needed, endoscopic ultrasound may prove to be an effective way of administering localized chemotherapy.

Case Studies

A 57-Year-Old Male with Rising PSA and Prior Negative Transrectal Biopsies

This patient, who had an increasing PSA level, was found to have abnormal PCA3 urine test results.

Metastatic Castrate Resistant Prostate Cancer

A 65-year-old male patient with a high PSA level and a bone scan showing new lesions requires a recommendation for the next treatment step.

Calcium/Vit D Supplementation for Stage III Breast Cancer

A woman with Stage III breast cancer who is about to undergo adjuvant chemotherapy needs a recommendation to maintain her bone health.

CME

Ponatinib Active in Patients with CML and Ph+ ALL Resistant/Intolerant to Dasatinib or Nilotinib or Who Have the T315I Mutation

Ponatinib Active in Patients with CML and Ph+ ALL Resistant/Intolerant to Dasatinib or Nilotinib or Who Have the T315I Mutation

This CME activity from ASCO 2012 reviews the results of the ongoing PACE (Ponatinib Ph+ ALL and CML Evaluation) trial.

Crizotinib Provides Clinically Meaningful Antitumor Activity in Patients with Previously Treated ALK-Positive Advanced Non-Small-Cell Lung Cancer

Crizotinib Provides Clinically Meaningful Antitumor Activity in Patients with Previously Treated ALK-Positive Advanced Non-Small-Cell Lung Cancer

This CME activity from ASCO 2012 reviews crizotinib in patients with ALK-positive non-small cell lung cancer.

From the Advisory Board

A Review of New Microhematuria Guidelines from the American Urological Association

A Review of New Microhematuria Guidelines from the American Urological Association

The guidelines include several departures from past recommendations on the diagnosis, workup, and evaluation of microhematuria.

Supportive Care

After Viewing Video of CPR, Fewer Patients with Advanced Cancer Opt for This Treatment

Patients with advanced cancer who viewed a video depicting a patient on a ventilator and cardiopulmonary resuscitation (CPR) being performed on a simulated patient were less likely to opt for CPR than those who listened to a verbal narrative, a study reported in the Journal of Clinical Oncology online December 10.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs